Clinical Trials for Severe Asthma

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

NCT ID: NCT06473779

This clinical trial is investigating whether a medication called tezepelumab can help people with severe asthma reduce their use of other asthma medications while still keeping their asthma under c...

Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

NCT ID: NCT06472310

The CORSAR trial is a study focused on understanding the characteristics of adults with uncontrolled severe asthma in Russia. Researchers are looking to gather information from about 5,000 patients...

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

NCT ID: NCT06966479

The VALOUR trial is a study designed to assess the long-term safety and effectiveness of a new medication called verekitug (also known as UPB-101) for adults with severe asthma. This trial is open ...

Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab

NCT ID: NCT07013123

This clinical trial is studying how well a new treatment called Acarizax works alongside an existing medication, Tezepelumab, for adults with severe asthma who are allergic to house dust mites. The...

Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres

NCT ID: NCT06455462

This clinical trial is looking at patients with severe asthma who have received a medication called tezepelumab. The researchers want to gather information from medical records to understand how pa...

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

NCT ID: NCT06998095

This clinical trial is studying a medication called tezepelumab (also known as Tezspire) for people with severe asthma in South Korea. The main goals of the study are to see how well this medicatio...

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma

NCT ID: NCT06985225

This clinical trial is studying how mucus plugs in the lungs affect breathing in people with severe asthma. Researchers will use a special imaging technique called xenon MRI to look at areas of the...

Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

NCT ID: NCT06566885

The ELBRUS trial is a research study looking at how effective a medication called tezepelumab is for people with severe asthma in Russia. This study will last for 12 months and will gather informat...

Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

NCT ID: NCT06916104

Experience of Biologic Treatments for Severe Asthma: a Survey

NCT ID: NCT06903780

This clinical trial is exploring the experiences of patients with severe asthma who are receiving biologic treatments. Severe asthma can cause serious breathing problems and affect many areas of li...

Swiss Severe Asthma Register

NCT ID: NCT03984253

The Swiss Severe Asthma Register is a clinical trial aimed at understanding severe asthma, a serious condition affecting about 5% of asthma patients. The study seeks to gather important information...

Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

NCT ID: NCT06705764

The TERA trial is studying a new medication called Tezepelumab, which is designed to help adults with severe asthma who often experience sudden and serious breathing problems that require emergency...

Withdrawal of Dupilumab in Severe Asthma

NCT ID: NCT06818019

This clinical trial is looking at what happens when patients with severe asthma stop taking a medication called dupilumab after using it for at least three years. Dupilumab helps many people manage...

Exploring the Lived Experience of Young Adults With Severe Asthma

NCT ID: NCT06681545

This clinical trial is looking to understand the experiences and needs of young adults, aged 16 to 25, who have severe or uncontrolled asthma. Asthma is a long-term condition that can make it hard ...

International Severe Asthma Registry: Canadian Cohort

NCT ID: NCT04045587

The International Severe Asthma Registry: Canadian Cohort is a study that aims to improve the care of people with severe asthma by collecting important health information from participants across C...

The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

NCT ID: NCT06666504

The TezEx Study is looking to understand why some patients with severe asthma continue to experience flare-ups, even while being treated with a medication called tezepelumab. This study is particul...

Register Schweres Asthma - German Asthma Net e.V.

NCT ID: NCT06035289

The Register Schweres Asthma trial, run by the German Asthma Net e.V., is studying severe asthma to improve how patients are treated and cared for. This research aims to gather detailed information...

Severe Asthma Network Italy

NCT ID: NCT06625216

The Severe Asthma Network Italy trial is focused on understanding how severe asthma affects patients in real life. Researchers are collecting information from patients who have been diagnosed with ...

Phenotyping Asthma for Bronchial Thermoplasty

NCT ID: NCT03435237

This clinical trial is studying a new imaging technology called optical coherence tomography (OCT) to better understand how the airways of patients with severe asthma respond to a treatment called ...

K-HEALTH in AIR - Barcelona Pilot - Cohort

NCT ID: NCT06421402